Physician profile
Said Samra
NPI 1023080140
$5,080.99
in general payments reported to CMS, 2019-2025
16 companies · $1,803 in 2025
The $1,803 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $338 · 2021: $566 · 2022: $207 · 2023: $1,124 · 2024: $550 · 2025: $1,803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,844 · Travel and Lodging: $616 · Education: $16.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,844.34 |
| Travel and Lodging | $615.95 |
| Education | $16.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,972.69 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Strattice Reconstructive Tissue Matrix Bps |
| Allergan, INC. | $512.57 | 2019-2022 | |
| Sientra, INC. | $472.19 | 2020-2021 | |
| Merz North America, INC. | $439.40 | 2019-2023 | Xeomin |
| Musculoskeletal Transplant Foundation INC. | $360.32 | 2024-2025 | |
| Motiva USA, LLC | $333.56 | 2025 | |
| Mentor Worldwide LLC | $315.34 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Tela Bio, INC. | $259.02 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Derma Sciences, INC. | $133.30 | 2019 | |
| Intuitive Surgical, INC. | $100.33 | 2023 | |
| Smith+Nephew, INC. | $46.10 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $33.35 | 2023-2024 | Exparel, Iovera |
| Axogen | $29.57 | 2020 | |
| Ethicon US, LLC | $25.08 | 2023 | Stratafix |
| Convatec INC. | $24.09 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $24.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Said Samra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.